NEW YORK, June 21 (GenomeWeb News) - Diagnostic developer Clinical Data plans to acquire Genaissance Pharmaceuticals in an all-stock transaction valued at $56 million, the companies said today.

 

The acquisition is expected to close in the fourth quarter.

 

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

US News & World Report writes that genetic testing of lung tumors can help identify treatments for patients.

A team of researchers plans to sample Loch Ness for environmental DNA, according to Newsweek.

The New York Times writes about the appearance of mosaicism in healthy people.

In PNAS this week: insecticide resistance patterns Anopheles gambiae mosquito, transcriptome patterns in Pseudomonas aeruginosa during infection, and more.